SARS-CoV-2 structural features may explain limited neutralizing-antibody responses

被引:43
|
作者
Bachmann, Martin F. [1 ,2 ,3 ]
Mohsen, Mona O. [2 ,3 ]
Zha, Lisha [1 ]
Vogel, Monique [1 ]
Speiser, Daniel E. [4 ,5 ]
机构
[1] Anhui Agr Univ, Int Immunol Ctr, Hefei, Peoples R China
[2] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland
[3] Univ Bern, Dept BioMed Res, Bern, Switzerland
[4] Univ Hosp, Lausanne, Switzerland
[5] Univ Lausanne, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
CORONAVIRUS; IMMUNITY; CELL; ANTIGEN; IMMUNOGENICITY; INFECTION;
D O I
10.1038/s41541-020-00264-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structural strategy to avoid strong and enduring antibody responses. Other viruses induce optimal and long-lived neutralizing antibody responses, thanks to 20 or more repetitive, rigid antigenic epitopes, spaced by 5-10nm, present on the viral surface. Such arrays of repetitive and highly organized structures are recognized by the immune system as pathogen-associated structural patterns (PASPs), which are characteristic for pathogen surfaces. In contrast, coronaviruses are large particles with long spikes (S protein) embedded in a fluid membrane. Therefore, the neutralizing epitopes (which are on the S protein) are loosely "floating" and widely spaced by an average of about 25nm. Consequently, recruitment of complement is poor and stimulation of B cells remains suboptimal, offering an explanation for the inefficient and short-lived neutralizing antibody responses.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
    Ekstrom, Nina
    Haveri, Anu
    Solastie, Anna
    Virta, Camilla
    Osterlund, Pamela
    Nohynek, Hanna
    Nieminen, Tuomo
    Ivaska, Lauri
    Tahtinen, Paula A.
    Lempainen, Johanna
    Jalkanen, Pinja
    Julkunen, Ilkka
    Palmu, Arto A.
    Melin, Merit
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (12):
  • [22] Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers
    Bonfante, Francesco
    Costenaro, Paola
    Cantarutti, Anna
    Di Chiara, Costanza
    Bortolami, Alessio
    Petrara, Maria Raffaella
    Carmona, Francesco
    Pagliari, Matteo
    Cosma, Chiara
    Cozzani, Sandra
    Mazzetto, Eva
    Di Salvo, Giovanni
    Da Dalt, Liviana
    Palma, Paolo
    Barzon, Luisa
    Corrao, Giovanni
    Terregino, Calogero
    Padoan, Andrea
    Plebani, Mario
    De Rossi, Anita
    Dona, Daniele
    Giaquinto, Carlo
    PEDIATRICS, 2021, 148 (03)
  • [23] Rational optimization of a human neutralizing antibody of SARS-CoV-2
    Chen, Jiao
    Wu, Fei
    Lin, Dan
    Kong, Weikang
    Cai, Xueting
    Yang, Jie
    Sun, Xiaoyan
    Cao, Peng
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 135
  • [24] Finally neutralizing the threat? A novel SARS-CoV-2 vaccine platform that elicits enhanced neutralizing antibody responses
    Salamango, Daniel J.
    MBIO, 2024, 15 (04):
  • [25] Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
    Anichini, Gabriele
    Terrosi, Chiara
    Savellini, Gianni Gori
    Gandolfo, Claudia
    Franchi, Federico
    Cusi, Maria Grazia
    VACCINES, 2021, 9 (05)
  • [26] SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
    Walls, Alexandra C.
    Sprouse, Kaitlin R.
    Bowen, John E.
    Joshi, Anshu
    Franko, Nicholas
    Navarro, Mary Jane
    Stewart, Cameron
    Cameroni, Elisabetta
    McCallum, Matthew
    Goecker, Erin A.
    Degli-Angeli, Emily J.
    Logue, Jenni
    Greninger, Alex
    Corti, Davide
    Chu, Helen Y.
    Veesler, David
    CELL, 2022, 185 (05) : 872 - +
  • [27] Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses
    Schlickeiser, Stephan
    Schwarz, Tatjana
    Steiner, Sophie
    Wittke, Kirsten
    Al Besher, Nabeel
    Meyer, Oliver
    Kalus, Ulrich
    Pruss, Axel
    Kurth, Florian
    Zoller, Thomas
    Witzenrath, Martin
    Sander, Leif Erik
    Mueller, Marcel A.
    Scheibenbogen, Carmen
    Volk, Hans-Dieter
    Drosten, Christian
    Corman, Victor M.
    Hanitsch, Leif G.
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [28] Longitudinal SARS-CoV-2 Antibody Avidity Responses in a SARS-CoV-2 Pregnancy Cohort
    Cassidy, Arianna
    Prahl, Mary
    Song, Dongli
    Jegatheesan, Priya
    Lynch, Kara
    Gaw, Stephanie
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : 297 - 298
  • [29] Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
    Reynolds, Catherine J.
    Swadling, Leo
    Gibbons, Joseph M.
    Pade, Corinna
    Jensen, Melanie P.
    Diniz, Mariana O.
    Schmidt, Nathalie M.
    Butler, David K.
    Amin, Oliver E.
    Bailey, Sasha N. L.
    Murray, Sam M.
    Pieper, Franziska P.
    Taylor, Stephen
    Jones, Jessica
    Jones, Meleri
    Lee, Wing-Yiu Jason
    Rosenheim, Joshua
    Chandran, Aneesh
    Joy, George
    Di Genova, Cecilia
    Temperton, Nigel
    Lambourne, Jonathan
    Cutino-Moguel, Teresa
    Andiapen, Mervyn
    Fontana, Marianna
    Smit, Angelique
    Semper, Amanda
    O'Brien, Ben
    Chain, Benjamin
    Brooks, Tim
    Manisty, Charlotte
    Treibel, Thomas
    Moon, James C.
    Noursadeghi, Mahdad
    Altmann, Daniel M.
    Maini, Mala K.
    McKnight, Aine
    Boyton, Rosemary J.
    SCIENCE IMMUNOLOGY, 2020, 5 (54)
  • [30] Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
    Walls, Alexandra C.
    Fiala, Brooke
    Schafer, Alexandra
    Wrenn, Samuel
    Pham, Minh N.
    Murphy, Michael
    Tse, Longping, V
    Shehata, Laila
    O'Connor, Megan A.
    Chen, Chengbo
    Navarro, Mary Jane
    Miranda, Marcos C.
    Pettie, Deleah
    Ravichandran, Rashmi
    Kraft, John C.
    Ogohara, Cassandra
    Palser, Anne
    Chalk, Sara
    Lee, E-Chiang
    Guerriero, Kathryn
    Kepl, Elizabeth
    Chow, Cameron M.
    Sydeman, Claire
    Hodge, Edgar A.
    Brown, Brieann
    Fuller, Jim T.
    Dinnon, Kenneth H., III
    Gralinski, Lisa E.
    Leist, Sarah R.
    Gully, Kendra L.
    Lewis, Thomas B.
    Guttman, Miklos
    Chu, Helen Y.
    Lee, Kelly K.
    Fuller, Deborah H.
    Baric, Ralph S.
    Kellam, Paul
    Carter, Lauren
    Pepper, Marion
    Sheahan, Timothy P.
    Veesler, David
    King, Neil P.
    CELL, 2020, 183 (05) : 1367 - +